Hangzhou criteria for liver transplantation in hepatocellular carcinoma: A single-center experience

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 2, 2014, Pages 200-204

  Lei, Jian Yong ^a   Wang, Wen Tao ^a   Yan, Lu Nan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Criteria; Hepatocellular carcinoma; Liver; Transplant

Indexed keywords

ADULT; ARTICLE; CANCER SURGERY; CHINA; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; ITALY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; CARCINOMA, HEPATOCELLULAR; DECISION SUPPORT SYSTEM; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

ADULT; CARCINOMA, HEPATOCELLULAR; CHINA; DECISION SUPPORT TECHNIQUES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84891850494     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283652b66     Document Type: Article

References (32)

1. Pankin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108
2. Lei JY, Yan LN. Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapy. J Gastrointest Surg 2012; 16:2120-2125
3. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362:1907-1917 (Pubitemid 37518510)
4. Choi HJ, Kim DG, Na GH, Hong TH, You YK. Extended criteria for living donor liver transplantation in patients with advanced hepatocellular carcinoma. Transplant Proc 2012; 44:399-402
5. Berry K, Ioannou GN. Serum alpha-fetoprotein level independently predicts post-transplantation survival in patients with hepatocellular carcinoma. Liver Transpl 2013; 19:634-645
6. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214:221-228
7. Mazzaferro V, Regalia E, Docu R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699 (Pubitemid 26079803)
8. Ferreira MV, Chaib E, Nascimento MU, Nersessian RS, Setughti DT, D'Albuguergur LA. Liver transplantation and expanded Milan criteria: does it really work? Arg Gastroenterol 2012; 49:189-194
9. de Ataide EC, Garcia M, Mattosinho TJ, Almeida JR, Escanhoela CA, Boin IF. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma. Transplant Proc 2012; 44:2438-2440
10. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002; 8:873-883 (Pubitemid 35154015)
11. Takada Y, Ito T, Ueda M, Sakamoto S, Haga H, Maetani Y, et al. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria. Dig Dis 2007; 25:299-302 (Pubitemid 350014956)
12. Lee SG, Hwang S, Moon DB, Ahn CS, Kim KH, Sung KB, et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl 2008; 14:935-945 (Pubitemid 352003892)
13. Fan J, Yang GS, Fu R, Peng ZH, Xia Q, Peng CH, et al. Liver transplantation outcomes in 1078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China. J Cancer Res Clin Oncol 2009; 135:1403-1412
14. Zheng SS, Xu X, Wu J, Chen J, Wang WL, Zhang M, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experience. Transplantation 2008; 85:1726-1732
15. Lei JY, Yan LN. Outcome comparisons among the Hangzhou, Chengdu and USCF criteria for hepatocellular carcinoma liver transplantation after successful downstaging therapies. J Gastrointest Surg 2013; 17:1116-1122
16. Takada Y, Uemoto S. Liver transplantation for hepatocellular carcinoma: the Kyoto experience. J Hepatobiliary Pancreat Sci 2010; 17:527-532
17. Roayaie S, Frischer J, Emre SH, Fishbein TM, Pa Sheiner, Sung M, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinoma larger than 5 centimeters. Ann Surg 2002; 235:533-539 (Pubitemid 34258353)
18. Kneteman N, Oberholzer J, Al Saghier M, Meeberg GA, Blitz M, Ma MM, et al. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transpl 2004; 10:1301-1311 (Pubitemid 39406087)
19. Martin AP, Bartels M, Hauss J, Fangmann J. Overview of the MELD score and the UNOS adult liver allocation system. Transplant Proc 2007; 39:3169-3174 (Pubitemid 350258645)
20. Lei JY, Yan LN, Wang W. Prediction factors of postoperative hyperbilirubinemia in living right lobe donor: a single-center analysis of 210 cases. Transplant Proc 2013; 45:205-211
21. Lei JY, Yan LN,Wang WT. Donor safety in living donor liver transplantation: a single-center analysis of 300 cases. PLoS One 2013; 8:e61769
22. Jiang L, Jiang LS, Cheng NS, Yan LN. Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol 2009; 15:2489-2499
23. Jiang L, Yan L, Li B, Wen T, Zhao J, Jiang L, et al. Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin. Am J Transplant 2010; 10:1861-1869
24. Bruix J, Sherman N, Liovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management on hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2005; 35:421-430
25. Llovet JM, Bruix J, Gores GJ. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology 2000; 31:1019-1021 (Pubitemid 30169952)
26. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10:35-43
27. Onaca N, Davis GL, Goldstein RM, Jennings LW, Klintmalm GB. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2007; 13:391-399 (Pubitemid 46444468)
28. Hsu CY, Huang YH, Hsia CY, Su CW, Lin HC, Loong CC, et al. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System. J Hepatol 2010; 53:108-117
29. Toso C, Asthana S, Bigam DL, Shapiro AM, Kneteman NM. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 2009; 49:832-838
30. Lee YH, Hsia CY, Hsu CY, Huang YJ, Lin HC, Huo TI. Total tumor volume is a better marker of tumor burden in hepatocellular carcinoma defined by the Milan criteria. World J Surg 2013; 37:1348-1355
31. Muscari F, Guinard JP, Kamar N, Peron JM, Otal P, Suc B. Impact of preoperative a-fetoprotein level on disease-free survival after liver transplantation for hepatocellular carcinoma. World J Surg 2012; 36:1824-1831
32. Balci D, Dayangac M, Yaprak O, Akin B, Duran C, Killi R, et al. Living donor liver transplantation for hepatocellular carcinoma: a single center analysis of outcomes and impact of different selection criteria. Transpl Int 2011; 24:1075-1083.